Target intelligence / Profile preview

Exosome component 4 (EXOSC4)

Target
EXOSC4
Molecular classification
Other (RNA exosome structural subunit, evolutionarily conserved protein complex)
01

Overview

Exosome component 4 (EXOSC4) is a structural subunit of the evolutionarily conserved RNA exosome complex, which is essential for the processing, maturation, and controlled degradation of multiple RNA species within the cell, including ribosomal RNA and aberrant transcripts. EXOSC4 (also known as RRP41) is one of the six core barrel-forming subunits of the exosome, interacting tightly with other subunits to maintain the integrity and function of the complex. Pathogenic mutations in EXOSC4 can destabilize the complex, reduce ribosome biogenesis, and are directly linked to rare neurodevelopmental disorders characterized by global developmental delay, cerebral calcifications, kidney dysfunction, and failure to thrive, indicating the critical requirement for intact exosome function for normal human development and homeostasis. EXOSC4 is not classically viewed as a primary drug target or receptor, but rather as a core molecular component of a fundamental RNA-processing machinery. Disruptions in EXOSC4 are increasingly recognized as genetic contributors to “RNA exosomopathies,” a set of human disorders with central nervous system and multi-organ manifestations. To date, drug interactions or targeted therapies against EXOSC4 have not been established, and there are no well-characterized biomarkers or mechanisms of action for pharmacologic targeting of this subunit.

Other names
Exosome complex component RRP41RRP41SKI6hRrp41pFLJ20591Rrp41pRRP41ASki6pp12AExosome component Rrp41ribosomal RNA-processing protein 41exosome complex exonuclease RRP41
02

Biological functions

RNA processing and decayRibonucleoprotein complex assemblyRibosomal RNA maturationDegradation of aberrant RNARegulation of messenger RNA levels
03

Disease associations

Neurodevelopmental disorderRenal failureGrowth disorder (failure to thrive, prenatal growth restriction)
04

Safety considerations

Genetic loss-of-function variants cause impaired RNA processing, neurodevelopmental defects, and multi-organ dysfunction

Beyond the preview

Go deeper on Exosome component 4 (EXOSC4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exosome component 4 (EXOSC4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call